ASND
Ascendis Pharma A/S
NASDAQ · DKHealthcareBiotechnology
$251.76-3.54%
Price as of Jul 20, 2026
ASND valuation
Ascendis Pharma A/S valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 33.16x
- P/E 2026E
- 47.04x
- P/E 2027E
- 20.94x
- P/E 2028E
- 14.29x
- P/S forward
- 8.26x
Trailing multiples
- P/E TTM
- 26.89x
- PEG TTM
- —
- Price / book
- 27.85x
- Price / sales
- 15.68x
- Price / cash flow
- 236.06x
Enterprise value
- Enterprise value
- $15.9B
- EV / sales
- 16.06x
- EV / EBITDA
- 1126.02x
- EV / EBIT
- -2009.73x
- Market cap
- $15.6B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.